AU Patent

AU2009256584B2 — Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases

Assigned to Astex Therapeutics Ltd · Expires 2014-06-12 · 12y expired

What this patent protects

The invention relates to new bicyclic heterocyclic derivative compounds, to pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.

USPTO Abstract

The invention relates to new bicyclic heterocyclic derivative compounds, to pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.

Drugs covered by this patent

Patent Metadata

Patent number: AU2009256584B2
Jurisdiction: AU
Classification: —
Expires: 2014-06-12
Drug substance claim: No
Drug product claim: No
Assignee: Astex Therapeutics Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.